1. Mendonça A, Santos H, Franco-Duarte R, Sampaio P. Fungal infections diagnosis-Past, present and future. Res Microbiol 2022; 173:103915.
2. Rodrigues ML, Nosanchuk JD. Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLoS Negl Trop Dis 2020; 14:e0007964.
3. Amy L Leber. Clinical Microbiology Procedures Handbook. 5th ed., ASM Press, Washington D.C., 2023.
4. Toda M, Williams SR, Berkow EL, Farley MM, Harrison LH, Bonner L et al. Population-Based Active Surveillance for Culture-Confirmed Candidemia-Four Sites, United States, 2012–2016.
MMWR Surveill Summ 2019; 68:1-15.
5. Beer KD, Farnon EC, Jain S, Jamerson C, Lineberger S, Miller J et al. Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure-Three States,
2010–2017. MMWR Morb Mortal Wkly Rep 2018; 67:1064-1067.
6. Kozel TR, Wickes B. Fungal Diagnostics. Cold Spring Harb Perspect Med. 2014;4:a019299.
7. Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev 2014; 27:490-526.
8. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014; 5:161–9.
9. Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision J Fungi (Basel). 2017; 3:57.
10. Jorgensen JH, Carroll KC, Funke G, Pfaller MA, Landry ML, Richter SS, Warnock DW, eds. Manual of Clinical Microbiology. 11th ed. ASM Press, Washington D.C., 2015.
11. Knoll MA, Steixner S, Lass-Flörl C. How to use direct microscopy for diagnosing fungal infections. Clin Microbiol Infect 2023; 29:1031–8.
12. Lass-Flörl C. How to make a fast diagnosis in invasive aspergillosis .Med Mycol 2019;57(Supplement_2): S155-S160.
13. White PL. Developments in Fungal Serology. Curr Fungal Infect Rep; 2023:1-12.
14. Bassetti M, Giacobbe DR, Grecchi C, Rebuffi C, Zuccaro V, Scudeller L; FUNDICU investigators. Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in
critically ill, adult patients: A systematic review with qualitative evidence synthesis. J Infect 2020; 81:131-146.
15. Bassetti M, Azoulay E, Kullberg BJ, Ruhnke M, Shoham S, Vazquez J, et al. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Wor-
king Group Clin Infect Dis. 2021;72(Suppl 2): S121-S127.
16. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis . Clin Infect Dis. 2006; 42:1417-27.
17. Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 2008; 27(4):245-51.
18. Thornton C, Johnson G, Agrawal S. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J Vis Exp. 2012; 61:3721.
19. Lass-Flörl C, Samardzic E, Knoll M. Serology anno 2021-fungal infections: from invasive to chronic . Clin Microbiol Infect. 2021; 27:1230-1241.
20. Pemán J, Ruiz-Gaitán A. Diagnosing invasive fungal infections in the laboratory today: It’s all good news? | Rev Iberoam Micol 2025; 42:1-14.
21. Lamoth F, Akan H, Andes D, Cruciani M, Marchetti O, Ostrosky-Zeichner L, et al. Assessment of the Role of 1,3-β-D-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults.
Clin Infect Dis. 2021;72(Suppl 2): S102-S108.
22. He S, Hang JP, Zhang L, Wang F, Zhang DC, Gong FH. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on
cutoff levels. J Microbiol Immunol Infect 2015; 48:351-61.
23. Duettmann W, Koidl C, Krause R, Lackner G, Woelfler A, Hoenigl M. Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies
at risk for fungal infection. Mycoses. 2016; 59:374-8.
24. Pini P, Colombari B, Marchi E, Castagnoli A, Venturelli C, Sarti M, et al. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG)
for diagnosis of invasive candidiasis (IC). Diagn Microbiol Infect Dis 2019; 93:39-43.
25. Diagnostic Value of Cryptococcal Glucuronoxylomannan Antigen Testing of Bronchoalveolar Lavage Fluid for Pulmonary Cryptococcosis in Immunocompetent Patients: A Clinical Study.
Ther Adv Pulm Crit Care Med 2025; 20:29768675251363301.
26. Rosam K, Steixner S, Bauer A, Lass-Flörl C. Non-conventional diagnostic methods for invasive fungal infections. Expert Rev Mol Diagn 2025; 25:313–27.
27. Pagano L, Fernández OM. Clinical aspects and recent advances in fungal diseases impacting human health. J Antimicrob Chemother 2025;80(Supplement-1): i2–8.
28. Pham D, Sivalingam V, Tang HM, Montgomery JM, Chen SCA, Halliday CL. Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches. J Fungi (Basel) 2024 26;
10:447.
29. Jenks JD, White PL, Kidd SE, Goshia T, Fraley SI, Hoenigl M, et al. An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections. Expert Rev Mol Diagn.
2023; 23:1135–52.
30. Pham D, Sivalingam V, Tang HM, Montgomery JM, Chen SCA, Halliday CL. Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches. J Fungi (Basel) 2024; 10:447.
31. Brown L, Cruciani M, Morton CO, Alanio A, Barnes RA, Donnelly JP, et al. The Molecular Diagnosis of Invasive Fungal Diseases with a Focus on PZR. Diagn 2025; 15:1909.
32. Chiu CY, Miller SA. Clinical metagenomics. Nat Rev Genet 2019; 20: 341-355.
33. Gu W, Miller SA, Chiu CY. Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection. Ann Rev Pathol 2019; 14:319–38